1,381
Views
5
CrossRef citations to date
0
Altmetric
Research Paper

The biological behavior of tRNA-derived fragment tRF-Leu-AAG in pancreatic cancer cells

, , , &
Pages 10617-10628 | Received 20 Jan 2022, Accepted 05 Apr 2022, Published online: 20 Apr 2022

References

  • Zanini S, Renzi S, Limongi AR, et al. A review of lifestyle and environment risk factors for pancreatic cancer. Eur J Cancer. 2021;145:53–70.
  • Collisson EA, Bailey P, Chang DK, et al. Molecular subtypes of pancreatic cancer. Nat Rev Gastroenterol Hepatol. 2019;16:207–220.
  • Zeng T, Hua Y, Sun C, et al. Relationship between tRNA‐derived fragments and human cancers. Int J Cancer. 2020;147:3007–3018.
  • Yu M, Lu B, Zhang J, et al. tRNA-derived RNA fragments in cancer: current status and future perspectives. J Hematol Oncol. 2020;13:121.
  • Xie Y, Yao L, Yu X, et al. Action mechanisms and research methods of tRNA-derived small RNAs. Vol. 5. Netherlands: Sig Transduct Target Ther; 2020. p. 109. https://doi.org/10.1038/s41392-020-00217-4
  • Ma Z, Zhou J, Shao Y, et al. Biochemical properties and progress in cancers of tRNA‐derived fragments. J Cell Biochem. 2020;121:2058–2063.
  • Balatti V, Pekarsky Y, Croce CM. Role of the tRNA-derived small RNAs in cancer: new potential biomarkers and target for therapy [Internet]. Advances in Cancer Research. Elsevier 2017;173–187. [cited 2021 Dec 25]. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0065230X17300180
  • Hu T, Chitnis N, Monos D, et al. Next-generation sequencing technologies: an overview. Hum Immunol. 2021;82:801–811.
  • Carithers LJ, Ardlie K, Barcus M, et al. A novel approach to high-quality postmortem tissue procurement: the GTEx project. Biopreserv Biobank. 2015;13:311–319.
  • Blum A, Wang P, Zenklusen JC. SnapShot: TCGA-analyzed tumors. Cell. 2018;173:530.
  • Chen L, Zhang Y-H, Wang S, et al. Prediction and analysis of essential genes using the enrichments of gene ontology and KEGG pathways. PLoS ONE. 2017;12:e0184129.
  • Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA A Cancer J Clin. 2019;69:7–34.
  • Ansari D, Tingstedt B, Andersson B, et al. Pancreatic cancer: yesterday, today and tomorrow. Future Oncol. 2016;12:1929–1946.
  • Zhang L, Sanagapalli S, Stoita A. Challenges in diagnosis of pancreatic cancer. Wjg. 2018;24:2047–2060.
  • Butturini G. Influence of resection margins and treatment on survival in patients with pancreatic cancer: meta-analysis of randomized controlled trials. Arch Surg. 2008;143:75.
  • Müller S, Raulefs S, Bruns P, et al. Next-generation sequencing reveals novel differentially regulated mRNAs, lncRNAs, miRNAs, sdRNAs and a piRNA in pancreatic cancer. Mol Cancer. 2015;14:94.
  • Kumar P, Kuscu C, Dutta A. Biogenesis and function of transfer RNA-related fragments (tRFs). Trends Biochem Sci. 2016;41:679–689.
  • Shen Y, Yu X, Zhu L, et al. Transfer RNA-derived fragments and tRNA halves: biogenesis, biological functions and their roles in diseases. J Mol Med. 2018;96:1167–1176.
  • Lee YS, Shibata Y, Malhotra A, et al. A novel class of small RNAs: tRNA-derived RNA fragments (tRFs). Genes Dev. 2009;23:2639–2649.
  • Haussecker D, Huang Y, Lau A, et al. Human tRNA-derived small RNAs in the global regulation of RNA silencing. RNA. 2010;16:673–695.
  • Maute RL, Schneider C, Sumazin P, et al. tRNA-derived microRNA modulates proliferation and the DNA damage response and is down-regulated in B cell lymphoma. Proc Natl Acad Sci USA. 2013;110:1404–1409.
  • Balatti V, Rizzotto L, Miller C, et al. TCL1 targeting miR-3676 is codeleted with tumor protein p53 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA. 2015;112:2169–2174.
  • Zhang M, Li F, Wang J, et al. tRNA-derived fragment tRF-03357 promotes cell proliferation, migration and invasion in high-grade serous ovarian cancer. OTT. 2019;12:6371–6383.
  • Brogna S, Ramanathan P, Wen J. UPF1 P-body localization. Biochem Soc Trans. 2008;36:698–700.
  • Shahid SOUPFP. Baking cookies, and the many targets of nonsense-mediated RNA decay. Plant Cell. 2020;32:2665–2666.
  • He J, Ma X. Interaction between LncRNA and UPF1 in tumors. Front Genet. 2021;12:624905.
  • Kim YK, Maquat LE. UPFront and center in RNA decay: UPF1 in nonsense-mediated mRNA decay and beyond. RNA. 2019;25:407–422.
  • Kalathiya P, Pawlicka V, Houston H, et al. Insights into the effects of cancer associated mutations at the UPF2 and ATP-binding sites of NMD master regulator: UPF1. Ijms. 2019;20:5644.
  • Ohnishi T, Yamashita A, Kashima I, et al. Phosphorylation of hUPF1 induces formation of mRNA surveillance complexes containing hSMG-5 and hSMG-7. Mol Cell. 2003;12:1187–1200.
  • Yamashita A, Ohnishi T, Kashima I, et al. Human SMG-1, a novel phosphatidylinositol 3-kinase-related protein kinase, associates with components of the mRNA surveillance complex and is involved in the regulation of nonsense-mediated mRNA decay. Genes Dev. 2001;15:2215–2228.
  • Liu C, Karam R, Zhou Y, et al. The UPF1 RNA surveillance gene is commonly mutated in pancreatic adenosquamous carcinoma. Nat Med. 2014;20:596–598.
  • Wang X, Lai Q, He J, et al. LncRNA SNHG6 promotes proliferation, invasion and migration in colorectal cancer cells by activating TGF-β/Smad signaling pathway via targeting UPF1 and inducing EMT via regulation of ZEB1. Int J Med Sci. 2019;16:51–59.
  • Raxwal VK, Simpson CG, Gloggnitzer J, et al. Nonsense-mediated RNA decay factor UPF1 is critical for posttranscriptional and translational gene regulation in Arabidopsis. Plant Cell. 2020;32:2725–2741.
  • Li C, Wu L, Liu P, et al. The C/D box small nucleolar RNA SNORD52 regulated by Upf1 facilitates hepatocarcinogenesis by stabilizing CDK1. Theranostics. 2020;10:9348–9363.
  • Wu Y, Liu Z, Tang D, et al. Potentially functional variants of HBEGF and ITPR3 in GnRH signaling pathway genes predict survival of non-small cell lung cancer patients. Transl Res. 2021;233:92–103.
  • Gründker C, Emons G. The role of gonadotropin-releasing hormone in cancer cell proliferation and metastasis. Front Endocrinol. 2017;8:187.